Exposure and Response Prevention With Behavioral- Versus Cognitive Therapy Rationale in Obsessive Compulsive Disorder
NCT ID: NCT00184262
Last Updated: 2012-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2003-01-31
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ERP to Improve Functioning in Veterans With OCD
NCT05240924
Inference-Based Cognitive Therapy Versus Exposure and Response Prevention for Obsessive-Compulsive Disorder
NCT03677947
Development of a Behavioral Team Intervention for Obsessive Compulsive Disorder
NCT02616341
Assessing Models of Exposure Therapy
NCT01679457
Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors
NCT00792038
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A randomized controlled trial including patients with OCD. 50 patients will receive 15 ERP sessions in 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ERP cognitive therapy
ERP cognitive therapy
15 exposure and response prevention (ERP) sessions in 3 months with a cognitive therapy rationale
ERP behavioral therapy
ERP behavioral therapy
15 exposure and response prevention (ERP) sessions in 3 months with a behavioral therapy rationale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ERP cognitive therapy
15 exposure and response prevention (ERP) sessions in 3 months with a cognitive therapy rationale
ERP behavioral therapy
15 exposure and response prevention (ERP) sessions in 3 months with a behavioral therapy rationale
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Foundation for Health and Rehabilitation
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
K. Gunnar Götestam, PhD MD
Role: PRINCIPAL_INVESTIGATOR
Norwegian University of Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norwegian University of Science and Technology, INM
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hansen B, Vogel PA, Stiles TC, Gotestam KG. Influence of co-morbid generalized anxiety disorder, panic disorder and personality disorders on the outcome of cognitive behavioural treatment of obsessive-compulsive disorder. Cogn Behav Ther. 2007;36(3):145-55. doi: 10.1080/16506070701259374.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4941.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.